SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001178913-20-003492
Filing Date
2020-12-31
Accepted
2020-12-31 16:37:11
Documents
11

Document Format Files

Seq Description Document Type Size
1 F-3 zk2025305.htm F-3 708384
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 75988
3 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 17300
4 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 4258
5 image0.jpg GRAPHIC 114720
6 image00002.jpg GRAPHIC 22619
7 image00003.jpg GRAPHIC 955
8 image00006.jpg GRAPHIC 3663
9 image00007.jpg GRAPHIC 3393
10 image00008.jpg GRAPHIC 5832
11 image00009.jpg GRAPHIC 89085
  Complete submission text file 0001178913-20-003492.txt   1133216
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-251857 | Film No.: 201429216
SIC: 2834 Pharmaceutical Preparations